ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Cupolillo E, Medina-Acosta E, Noyes H, Momen H, Grimaldi G Jr, 2000. A revised classification for Leishmania and Endotrypanum. Parasitol Today 16 :142–144.
-
2
Grimaldi G Jr, Tesh RB, 1993. Leishmaniasis of the New World: current concepts and implications for future research. Clin Microbiol Rev 6 :230–250.
-
3
Greenblatt CL, 1985. Vaccination for leishmaniasis. Chang K.-P, Bray RS, eds. Leishmaniasis. London: Elsevier, 199–212.
-
4
Gunders AE, 1987. Vaccination: past and future role in control. Peters W, Killick-Kendrick R, eds. The Leishmaniasis in Biology and Medicine. Volume 2. London: Academic Press, 928–941.
-
5
Grimaldi G Jr, 1995. Meeting on vaccine studies towards the control of leishmaniasis. Mem Inst Oswaldo Cruz 90 :553–556.
-
6
Alexander J, Phillips RS, 1978. Leishmania tropica and Leishmania mexicana: cross-immunity in mice. Exp Parasitol 45 :93–100.
-
7
Perez H, Arredondo B, Machado R, 1979. Leishmania mexicana and Leishmania tropica: cross-immunity inC57BL/6 mice. Exp Parasitol 48 :9–14.
-
8
Alexander J, 1982. A radioattenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana. Trans R Soc Trop Med Hyg 76 :646–649.
-
9
Alexander J, 1988. Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major. Parasitology 96 :297–302.
-
10
Blackwell JM, Alexander J, 1986. Different host genes recognize and control infection with taxonomically distinct Leishmania species. Rioux J-A, ed. Leishmania: Taxonomie et Phylogenese. Aplications Eco-Epidemiologiques. Montpellier: Institut Mediterraneen d’Etudes Epidemiologiques et Ecologiques, 211–219.
-
11
Cuba Cuba CA, Ferreira V, Bampi M, Magalhães A, Marsden PD, Vexenat A, De Mello MT, 1990. Experimental infection with Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the marmoset, Callithrix penicillata (Primates: Callithricidae). Mem Inst Oswaldo Cruz 85 :459–467.
-
12
Lujan R, Dennis VA, Chapman WL Jr, Hanson WL, 1986. Blastogenic responses of peripheral blood leukocytes from owl monkeys experimentally infected with Leishmania braziliensis panamensis. Am J Trop Med Hyg 35 :1103–1109.
-
13
Teva A, Porrozzi R, Cupolillo E, Pirmez C, Oliveira-Neto MP, Grimaldi G Jr, 2003. Experimental mucocutaneous leishmaniasis in rhesus macaques (Macaca mulatta) following Leishmania (Viannia) braziliensis infection. Parasitology 127 :1–11.
-
14
Lainson R, Bray RS, 1966. Studies on the immunology and serology of leishmaniasis. II. Cross-immunity experiments among different forms of American cutaneous leishmaniasis in monkeys. Trans R Soc Trop Med Hyg 60 :526–532.
-
15
Lainson R, Shaw JJ, 1977. Leishmaniasis in Brazil: XII. Observations on cross-immunity in monkeys and man infected with Leishmania mexicana mexicana, L. m. amazonensis, L. braziliensis braziliensis, L. b. guyanensis and L. b. panamensis. J Trop Med Hyg 80 :29–35.
-
16
Gicheru MM, Olobo JO, Anjili CO, 1997. Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease. Exp Parasitol 85 :109–116.
-
17
Lujan R, Chapman WL Jr, Hanson WL, Dennis VA, 1990. Leishmania braziliensis in the squirrel monkeys: development of primary and satellite lesions and lack of cross-immunity with Leishmania donovani. J Parasitol 76 :594–597.
-
18
Amaral VF, V. Ransatto AO, Conceição-Silva F, Molinaro E, Ferreira V, Coutinho SG, McMahon-Pratt D, Grimaldi G Jr, 1996. Leishmania amazonensis: the Asian rhesus macaques (Macaca mulatta) as an experimental model for study of cutaneous leishmaniasis. Exp Parasitol 82 :34–44.
-
19
Amaral VF, Teva A, Porrozzi R, Silva AJ, Pereira MS, Grimaldi G Jr, 2001. Leishmania (Leishmania) major-infected rhesus macaques (Macaca mulatta) develop varying levels of resistance against homologous reinfections. Mem Inst Oswaldo Cruz 96 :795–804.
-
20
Kenney RT, Sacks DL, Sypek JP, Vilela L, Gam AA, Evans-Davis K, 1999. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J Immunol 163 :4481–4488.
-
21
Campos-Neto A, Porrozzi R, Greeson K, Coler RN, Webb JR, Seiky YA, Reed SG, Grimaldi G Jr, 2001. Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infect Immun 69 :4103–4108.
-
22
Cupolillo E, Momen H, Grimaldi G Jr, 1998. Genetic diversity in natural populations of New World Leishmania. Mem Inst Oswaldo Cruz 93 :663–668.
-
23
Killick-Kendrick R, Bryceson ADM, Peter W, Evans DA, Leaney AJ, Rioux JÁ, 1985. Zoonotic cutaneous leishmaniasis in Saudi Arabia: lesions healing naturally in man followed by a second infection with the same zymodeme of Leishmania major. Trans R Soc Trop Med Hyg 79 :363–365.
-
24
Saravia NG, Weigle K, Segura I, Giannini SH, Pacheco R, Labrada LA, Gonçalves A, 1990. Recurrent lesions in humans Leishmania braziliensis infection – reactivation or reinfection? Lancet 336 :398–402.
-
25
Dennis VA, Lujan R, Chapman WL Jr, Hanson WL, 1986. Leishmania donovani: cellular and humoral immune responses after primary and challenge infections in squirrel monkeys, Saimiri sciureus. Exp Parasitol 61 :319–334.
-
26
Olobo JO, Reid GD, Githure JI, Anjili CO, 1992. IFN-gamma and delayed-type hypersensitivity are associated with cutaneous leishmaniasis in vervet monkeys following secondary re-challenge with Leishmania major. Scand J Immunol 11 :48–52.
-
27
Githure JI, Reid GD, Binhazim AA, Anjili CO, ShatryAM, Hendricks LD, 1987. Leishmania major: the suitability of East African nonhuman primates as animal models for cutaneous leishmaniasis. Exp Parasitol 64 :438–447.
-
28
Probst RJ, Wellde BT, Lawyer PG, Stiteler JS, Rowton ED, 2001. Rhesus monkey model for Leishmania major transmitted by Phlebotomus papatasi sandfly bites. Med Vet Entomol 15 :12–21.
-
29
Reed SG, Scott P, 2000. Immunologic mechanisms in Leishmania. Cunningham MW, Fujinami RS, eds. Effects of Microbes on the Immune System. Philadelphia: Lippincott Williams & Wilkins, 537–554.
-
30
Saraiva NG, Valderrama L, Labrada M, Holguin AF, Navas C, Palma G, Weigle KA, 1989. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. J Infect Dis 159 :725–735.
-
31
Gicheru MM, Olobo JO, Anjili CO, Orago AS, Modabber F, Scott P, 2001. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Infect Immun 69 :245–251.
-
32
Oliveira Neto MP, Marzochi MCA, Grimaldi Jr G, Toledo LM, Momen H, 1986. Concurrent human infection with Leishmania braziliensis braziliensis and L. donovani chagasi. Ann Trop Med Parasitol 80 :587–592.
-
33
Parrot L, Donatien A, Lestoquard F, 1927. Notes expérimentales sur le bouton d’orient et sur la leishmaniose canine viscérale. Arch Inst Pasteur Alger 5 :120–130.
-
34
Ranque J, Depieds R, Nicole RM, 1960. Les phénomènes d’immunité dans les leishmanioses. Pathol Biol (Paris) 8 :99–107.
-
35
Camargo ME, Rebonato C, 1969. Cross reactivity in immunofluorescent test for Trypanosoma and Leishmania antibodies. Am J Trop Med Hyg 18 :500–505.
-
36
Rosell AR, Bray RS, Alexander J, 1987. The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis. Parasite Immunol 9 :105–115.
-
37
Nurit R, Jaffe CL, 1993. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. J Immunol 150 :2322–2331.
-
38
Leclerc C, Modabber F, Deriaud F, Chedid L, 1981. Systemic infection of Leishmania tropica (major) in various strains of mice. Trans R Soc Trop Med Hyg 75 :851–854.
-
39
Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 :502–507.
-
40
Modabber F, 1989. Experiences with vaccines against cutaneous leishmaniasis: Of mem and mice. Parasitology 98 :S49–S60.
-
41
Senekji HA, 1943. Hematologic and immunologic studies on natural and induced leishmaniasis in paretics. Am J Trop Med 23 :53–58.
-
42
Ansari N, Mofidi C, 1950. Contribution à l’étude des “formes humides” de leishmaniose cutanée. Bull Soc Pathol Exot Filial 43 :601–607.
-
43
Adler S, Gunders AE, 1964. Immunity to Leishmania mexicana following spontaneous recovery from oriental sore. Trans R Soc Trop Med Hyg 58 :274–277.
-
44
Lainson R, Shaw JJ, 1966. Studies on the immunology and serology of leishmaniasis. III. Cross-immunity between Panamanian cutaneous leishmaniasis and Leishmania mexicana infection in man. Trans R Soc Trop Med Hyg 60 :533–535.
-
45
Pung OJ, Hulsebos LH, Kuhn RE, 1988. Experimental American leishmaniasis and chagas’ disease in the Brazilian squirrel monkey: cross immunity and electrocardiographic studies of monkeys infected with Leishmania braziliensis and Trypanosoma cruzi.Int J Parasitol 18 :1053–1059.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 824 | 721 | 64 |
| Full Text Views | 434 | 8 | 0 |
| PDF Downloads | 188 | 7 | 0 |
CROSS-IMMUNITY EXPERIMENTS BETWEEN DIFFERENT SPECIES OR STRAINS OF LEISHMANIA IN RHESUS MACAQUES (MACACA MULATTA)
RENATO PORROZZI
RENATO PORROZZI
Departments of Immunology and Ultrastructural and Cell Biology, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil
Search for other papers by RENATO PORROZZI in
Current site
Google Scholar
PubMed
Search for other papers by RENATO PORROZZI in
Current site
Google Scholar
PubMed
ANTONIO TEVA
ANTONIO TEVA
Departments of Immunology and Ultrastructural and Cell Biology, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil
Search for other papers by ANTONIO TEVA in
Current site
Google Scholar
PubMed
Search for other papers by ANTONIO TEVA in
Current site
Google Scholar
PubMed
VERONICA F. AMARAL
VERONICA F. AMARAL
Departments of Immunology and Ultrastructural and Cell Biology, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil
Search for other papers by VERONICA F. AMARAL in
Current site
Google Scholar
PubMed
Search for other papers by VERONICA F. AMARAL in
Current site
Google Scholar
PubMed
MARCOS V. SANTOS DA COSTA
MARCOS V. SANTOS DA COSTA
Departments of Immunology and Ultrastructural and Cell Biology, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil
Search for other papers by MARCOS V. SANTOS DA COSTA in
Current site
Google Scholar
PubMed
Search for other papers by MARCOS V. SANTOS DA COSTA in
Current site
Google Scholar
PubMed
GABRIEL GRIMALDI JR.
GABRIEL GRIMALDI JR.
Departments of Immunology and Ultrastructural and Cell Biology, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil
Search for other papers by GABRIEL GRIMALDI JR. in
Current site
Google Scholar
PubMed
Search for other papers by GABRIEL GRIMALDI JR. in
Current site
Google Scholar
PubMed
This study evaluates cross-immunity in rhesus monkeys (Macaca mulatta) previously infected with one species of Leishmania and have had self-cured disease or were cured by antimony-based therapy upon development of full-blown disease. We found that a self-healing cutaneous leishmaniasis (CL) following experimental infection with Leishmania (Leishmania) major induces significant protection for L. (L.) amazonensis and L. (Viannia) guyanensis, and was dependent on time of re-challenge by L (L.) amazonensis after animals had recovered from primary lesions, but lacked protection against L. (V.) braziliensis. In contrast, monkeys that recovered from L. (V.) braziliensis CL or L. (L.) chagasi visceral leishmaniasis following chemotherapeutic intervention were protected by challenge with L. (V.) braziliensis and L (L.) amazonensis. These findings indicate the relative variability in protection after self-cure or drug-cured experimental leishmaniasis to challenge by heterologous leishmanial parasites. Further studying the immune response may provide information regarding relevant factors influencing cross-protective immunity.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Cupolillo E, Medina-Acosta E, Noyes H, Momen H, Grimaldi G Jr, 2000. A revised classification for Leishmania and Endotrypanum. Parasitol Today 16 :142–144.
-
2
Grimaldi G Jr, Tesh RB, 1993. Leishmaniasis of the New World: current concepts and implications for future research. Clin Microbiol Rev 6 :230–250.
-
3
Greenblatt CL, 1985. Vaccination for leishmaniasis. Chang K.-P, Bray RS, eds. Leishmaniasis. London: Elsevier, 199–212.
-
4
Gunders AE, 1987. Vaccination: past and future role in control. Peters W, Killick-Kendrick R, eds. The Leishmaniasis in Biology and Medicine. Volume 2. London: Academic Press, 928–941.
-
5
Grimaldi G Jr, 1995. Meeting on vaccine studies towards the control of leishmaniasis. Mem Inst Oswaldo Cruz 90 :553–556.
-
6
Alexander J, Phillips RS, 1978. Leishmania tropica and Leishmania mexicana: cross-immunity in mice. Exp Parasitol 45 :93–100.
-
7
Perez H, Arredondo B, Machado R, 1979. Leishmania mexicana and Leishmania tropica: cross-immunity inC57BL/6 mice. Exp Parasitol 48 :9–14.
-
8
Alexander J, 1982. A radioattenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana. Trans R Soc Trop Med Hyg 76 :646–649.
-
9
Alexander J, 1988. Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major. Parasitology 96 :297–302.
-
10
Blackwell JM, Alexander J, 1986. Different host genes recognize and control infection with taxonomically distinct Leishmania species. Rioux J-A, ed. Leishmania: Taxonomie et Phylogenese. Aplications Eco-Epidemiologiques. Montpellier: Institut Mediterraneen d’Etudes Epidemiologiques et Ecologiques, 211–219.
-
11
Cuba Cuba CA, Ferreira V, Bampi M, Magalhães A, Marsden PD, Vexenat A, De Mello MT, 1990. Experimental infection with Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the marmoset, Callithrix penicillata (Primates: Callithricidae). Mem Inst Oswaldo Cruz 85 :459–467.
-
12
Lujan R, Dennis VA, Chapman WL Jr, Hanson WL, 1986. Blastogenic responses of peripheral blood leukocytes from owl monkeys experimentally infected with Leishmania braziliensis panamensis. Am J Trop Med Hyg 35 :1103–1109.
-
13
Teva A, Porrozzi R, Cupolillo E, Pirmez C, Oliveira-Neto MP, Grimaldi G Jr, 2003. Experimental mucocutaneous leishmaniasis in rhesus macaques (Macaca mulatta) following Leishmania (Viannia) braziliensis infection. Parasitology 127 :1–11.
-
14
Lainson R, Bray RS, 1966. Studies on the immunology and serology of leishmaniasis. II. Cross-immunity experiments among different forms of American cutaneous leishmaniasis in monkeys. Trans R Soc Trop Med Hyg 60 :526–532.
-
15
Lainson R, Shaw JJ, 1977. Leishmaniasis in Brazil: XII. Observations on cross-immunity in monkeys and man infected with Leishmania mexicana mexicana, L. m. amazonensis, L. braziliensis braziliensis, L. b. guyanensis and L. b. panamensis. J Trop Med Hyg 80 :29–35.
-
16
Gicheru MM, Olobo JO, Anjili CO, 1997. Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease. Exp Parasitol 85 :109–116.
-
17
Lujan R, Chapman WL Jr, Hanson WL, Dennis VA, 1990. Leishmania braziliensis in the squirrel monkeys: development of primary and satellite lesions and lack of cross-immunity with Leishmania donovani. J Parasitol 76 :594–597.
-
18
Amaral VF, V. Ransatto AO, Conceição-Silva F, Molinaro E, Ferreira V, Coutinho SG, McMahon-Pratt D, Grimaldi G Jr, 1996. Leishmania amazonensis: the Asian rhesus macaques (Macaca mulatta) as an experimental model for study of cutaneous leishmaniasis. Exp Parasitol 82 :34–44.
-
19
Amaral VF, Teva A, Porrozzi R, Silva AJ, Pereira MS, Grimaldi G Jr, 2001. Leishmania (Leishmania) major-infected rhesus macaques (Macaca mulatta) develop varying levels of resistance against homologous reinfections. Mem Inst Oswaldo Cruz 96 :795–804.
-
20
Kenney RT, Sacks DL, Sypek JP, Vilela L, Gam AA, Evans-Davis K, 1999. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J Immunol 163 :4481–4488.
-
21
Campos-Neto A, Porrozzi R, Greeson K, Coler RN, Webb JR, Seiky YA, Reed SG, Grimaldi G Jr, 2001. Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infect Immun 69 :4103–4108.
-
22
Cupolillo E, Momen H, Grimaldi G Jr, 1998. Genetic diversity in natural populations of New World Leishmania. Mem Inst Oswaldo Cruz 93 :663–668.
-
23
Killick-Kendrick R, Bryceson ADM, Peter W, Evans DA, Leaney AJ, Rioux JÁ, 1985. Zoonotic cutaneous leishmaniasis in Saudi Arabia: lesions healing naturally in man followed by a second infection with the same zymodeme of Leishmania major. Trans R Soc Trop Med Hyg 79 :363–365.
-
24
Saravia NG, Weigle K, Segura I, Giannini SH, Pacheco R, Labrada LA, Gonçalves A, 1990. Recurrent lesions in humans Leishmania braziliensis infection – reactivation or reinfection? Lancet 336 :398–402.
-
25
Dennis VA, Lujan R, Chapman WL Jr, Hanson WL, 1986. Leishmania donovani: cellular and humoral immune responses after primary and challenge infections in squirrel monkeys, Saimiri sciureus. Exp Parasitol 61 :319–334.
-
26
Olobo JO, Reid GD, Githure JI, Anjili CO, 1992. IFN-gamma and delayed-type hypersensitivity are associated with cutaneous leishmaniasis in vervet monkeys following secondary re-challenge with Leishmania major. Scand J Immunol 11 :48–52.
-
27
Githure JI, Reid GD, Binhazim AA, Anjili CO, ShatryAM, Hendricks LD, 1987. Leishmania major: the suitability of East African nonhuman primates as animal models for cutaneous leishmaniasis. Exp Parasitol 64 :438–447.
-
28
Probst RJ, Wellde BT, Lawyer PG, Stiteler JS, Rowton ED, 2001. Rhesus monkey model for Leishmania major transmitted by Phlebotomus papatasi sandfly bites. Med Vet Entomol 15 :12–21.
-
29
Reed SG, Scott P, 2000. Immunologic mechanisms in Leishmania. Cunningham MW, Fujinami RS, eds. Effects of Microbes on the Immune System. Philadelphia: Lippincott Williams & Wilkins, 537–554.
-
30
Saraiva NG, Valderrama L, Labrada M, Holguin AF, Navas C, Palma G, Weigle KA, 1989. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. J Infect Dis 159 :725–735.
-
31
Gicheru MM, Olobo JO, Anjili CO, Orago AS, Modabber F, Scott P, 2001. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Infect Immun 69 :245–251.
-
32
Oliveira Neto MP, Marzochi MCA, Grimaldi Jr G, Toledo LM, Momen H, 1986. Concurrent human infection with Leishmania braziliensis braziliensis and L. donovani chagasi. Ann Trop Med Parasitol 80 :587–592.
-
33
Parrot L, Donatien A, Lestoquard F, 1927. Notes expérimentales sur le bouton d’orient et sur la leishmaniose canine viscérale. Arch Inst Pasteur Alger 5 :120–130.
-
34
Ranque J, Depieds R, Nicole RM, 1960. Les phénomènes d’immunité dans les leishmanioses. Pathol Biol (Paris) 8 :99–107.
-
35
Camargo ME, Rebonato C, 1969. Cross reactivity in immunofluorescent test for Trypanosoma and Leishmania antibodies. Am J Trop Med Hyg 18 :500–505.
-
36
Rosell AR, Bray RS, Alexander J, 1987. The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis. Parasite Immunol 9 :105–115.
-
37
Nurit R, Jaffe CL, 1993. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. J Immunol 150 :2322–2331.
-
38
Leclerc C, Modabber F, Deriaud F, Chedid L, 1981. Systemic infection of Leishmania tropica (major) in various strains of mice. Trans R Soc Trop Med Hyg 75 :851–854.
-
39
Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 :502–507.
-
40
Modabber F, 1989. Experiences with vaccines against cutaneous leishmaniasis: Of mem and mice. Parasitology 98 :S49–S60.
-
41
Senekji HA, 1943. Hematologic and immunologic studies on natural and induced leishmaniasis in paretics. Am J Trop Med 23 :53–58.
-
42
Ansari N, Mofidi C, 1950. Contribution à l’étude des “formes humides” de leishmaniose cutanée. Bull Soc Pathol Exot Filial 43 :601–607.
-
43
Adler S, Gunders AE, 1964. Immunity to Leishmania mexicana following spontaneous recovery from oriental sore. Trans R Soc Trop Med Hyg 58 :274–277.
-
44
Lainson R, Shaw JJ, 1966. Studies on the immunology and serology of leishmaniasis. III. Cross-immunity between Panamanian cutaneous leishmaniasis and Leishmania mexicana infection in man. Trans R Soc Trop Med Hyg 60 :533–535.
-
45
Pung OJ, Hulsebos LH, Kuhn RE, 1988. Experimental American leishmaniasis and chagas’ disease in the Brazilian squirrel monkey: cross immunity and electrocardiographic studies of monkeys infected with Leishmania braziliensis and Trypanosoma cruzi.Int J Parasitol 18 :1053–1059.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 824 | 721 | 64 |
| Full Text Views | 434 | 8 | 0 |
| PDF Downloads | 188 | 7 | 0 |